Literature DB >> 16882067

Renal cell carcinoma with non-islet cell tumor hypoglycemia.

Herman S Fernando1, Simon J Hawkyard, Philip Poon, Mohammed Musa.   

Abstract

We report a case of an elderly gentleman with renal cell carcinoma presenting with the rare entity of non-islet cell tumor hypoglycemia (NICTH). Non-islet cell tumor hypoglycemia syndrome is caused by the tumor producing insulin-like growth factor II, causing hypoglycemia. The syndrome is most commonly associated with very large fibromas or fibrosarcomas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16882067     DOI: 10.1111/j.1442-2042.2006.01452.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  5 in total

Review 1.  Management of non-islet-cell tumor hypoglycemia: a clinical review.

Authors:  Timothy W Bodnar; Maria J Acevedo; Massimo Pietropaolo
Journal:  J Clin Endocrinol Metab       Date:  2013-12-11       Impact factor: 5.958

2.  External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma.

Authors:  Nathan E Hoffmann; Yuri Sheinin; Christine M Lohse; Alexander S Parker; Bradley C Leibovich; Zhong Jiang; Eugene D Kwon
Journal:  Cancer       Date:  2008-04-01       Impact factor: 6.860

3.  Recurrent Non-islet Cell Tumor Hypoglycemia Secondary to Recurrent Renal Sarcoma.

Authors:  John O Kelly; Gregory J Nason; Christine Shilling; Maeve Redmond; Dilly M Little
Journal:  Curr Urol       Date:  2015-11-10

4.  Non- pancreatic neuroendocrine tumour presenting with hypoglycemia in an elderly patient.

Authors:  Merve Eren; Feyzi Bostan
Journal:  Afr Health Sci       Date:  2020-12       Impact factor: 0.927

5.  Refractory spontaneous hypoglycaemia: a diagnostic conundrum

Authors:  Seong Keat Cheah; David Halsall; Peter Barker; John Grant; Abraham Mathews; Shyam Seshadri; Singhan Krishnan
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2018-09-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.